Vivo Capital VIII, LLC - Apr 23, 2025 SCHEDULE 13D/A Report for Sinovac Biotech Ltd. (SVA)

Filing Manager: Vivo Capital VIII, LLC
Reporting Manager: Vivo Capital IX, LLC
Security: Sinovac Biotech Ltd. Common Shares, $0.001 par value per share
Symbol: SVA
Shares outstanding: 72.1M shares
Disclosed Ownership: 4.54M shares
Ownership: 6.3%
Form type: SCHEDULE 13D/A
Date filed: 4/24/2025, 05:00 PM
Date of event: Apr 23, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vivo Capital VIII, LLC	1.9%	1.36M	0	1.36M	/s/ Dr. Frank Kung	Dr. Frank Kung, Managing Member	0001618789
Vivo Capital IX, LLC	6.3%	4.54M	0	4.54M	/s/ Dr. Frank Kung	Dr. Frank Kung, Managing Member	0001750698